C095-0108 Screening compound: (2E)-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]-3-[2-(propan-2-yloxy)phenyl]prop-2-enamide

C095-0108 Screening compound: (2E)-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]-3-[2-(propan-2-yloxy)phenyl]prop-2-enamide
C095-0108 Screening compound: (2E)-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]-3-[2-(propan-2-yloxy)phenyl]prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C095-0108
(2E)-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]-3-[2-(propan-2-yloxy)phenyl]prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C095-0108

Molecular Formula

C27H31N3O2 (C27 H31 N3 O2)

Compound Name

(2E)-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]-3-[2-(propan-2-yloxy)phenyl]prop-2-enamide

IUPAC name

(2E)-N-[4-methyl-2-(piperidin-1-yl)quinolin-6-yl]-3-[2-(propan-2-yloxy)phenyl]prop-2-enamide

SMILES

CC(C)Oc1c(/C=C/C(Nc2cc3c(C)cc(N4CCCCC4)nc3cc2)=O)cccc1

InChI

InChI=1S/C27H31N3O2/c1-19(2)32-25-10-6-5-9-21(25)11-14-27(31)28-22-12-13-24-23(18-22)20(3)17-26(29-24)30-15-7-4-8-16-30/h5-6,9-14,17-19H,4,7-8,15-16H2,1-3H3,(H,28,31)

InChI Key

RSCBMCLZICEJOS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14719055

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

429.56

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.848

Distribution Coefficient, logD

6.847

Water Solubility, LogSw

-5.62

Polar Surface Area

41.252

Acid Dissociation Constant (pKa)

11.62

Base Dissociation Constant (pKb)

4.83

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

C095-0108 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Human Kinases Annotated Library (2415 compounds)

Human Proteases Annotated Library (2868 compounds)

Lipid Metabolism Library (9174 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cardiovascular
  • Metabolic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with C095-0108 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C095-0108?
Check Price and Availability of C095-0108, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C095-0108 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C095-0108
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C095-0108
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C095-0108 available by request